January 27, 2022 – Enterin KOL Event Replay: Enterin Meets Study Endpoints for Phase 2b (KARMET) Study Involving Patients with Parkinson’s Disease
Event Information
On January 27, 2022 at 2:30 pm EST, top-line results from the Phase 2b (KARMET) study were presented on a conference call by Denise Barbut, MD, FRCP, Co-Founder, President and CMO of Enterin. Stuart Isaacson, MD, and Patrik Brundin, MD, Ph.D., shared their perspectives. A replay of the event is available here.
